NYSE:BMYPharmaceuticals
Bristol-Myers Squibb (BMY) Is Up 8.7% After Swing To Profit And AI-Focused R&D Push
Bristol-Myers Squibb recently reported its fourth-quarter and full-year 2025 results, showing quarterly revenue of US$12,502 million and a swing from a prior-year net loss to full-year net income of US$7.05 billion.
Beyond the headline numbers, management highlighted a data-rich 2026 with multiple pivotal pipeline readouts and new AI-enabled trial design collaboration, underscoring a sharpened focus on future drug development productivity.
Next, we’ll examine how this earnings momentum,...